Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease
In patients with heart failure (HF) caused by Chagas disease, sacubitril/valsartan was superior to enalapril for the composite primary endpoint, predominantly driven by a significant reduction in N-terminal pro-B-type natriuretic…